NewsBenzingaEli Lilly anuncia que Foundayo alcanzó el criterio de valoración principal en la semana 52 del ensayo ATTAIN-OSA para reducir el índice de apnea-hipopnea; reduce la carga hipóxica específica de la apnea del sueño hasta en un promedio del 55,9% Eli Lilly anuncia que Foundayo alcanzó el criterio de valoración principal en la semana 52 del ensayo ATTAIN-OSA para reducir el índice de apnea-hipopnea; reduce la carga hipóxica específica de la apnea del sueño hasta en un promedio del 55,9% Benzinga 2026.11.09 14:33 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares